---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-015753"
form_type: "8-K"
ticker: "UNCY"
cik: "0001766140"
company_name: "Unicycive Therapeutics, Inc."
filed_at: "2024-02-21T23:59:59+00:00"
generated_at: "2026-06-05T22:12:35.141668+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Unicycive regains compliance with Nasdaq minimum market value and bid price rules

## Summary
- On Feb 21, 2024, Nasdaq notified Unicycive that it regained compliance with the $35M minimum market value and $1.00 minimum bid price requirements.
- Non-compliance notices were originally received on Sept 19, 2023, for both Nasdaq Listing Rules 5550(b)(2) and 5550(a)(2).
- The compliance matters are now closed with no further action required.

## SEC filing metadata
- accession: 0001213900-24-015753
- form_type: 8-K
- ticker: UNCY
- cik: 0001766140
- company_name: Unicycive Therapeutics, Inc.
- filed_at: 2024-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1766140/000121390024015753/0001213900-24-015753-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1766140/000121390024015753/ea0200428-8k_unicyc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-015753
- JSON: https://secwatch.observer/filing/0001213900-24-015753.json
- Plain text: https://secwatch.observer/filing/0001213900-24-015753.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.